Galectin Therapeutics Inc (GALT)
1.15
+0.28
(+32.17%)
USD |
NASDAQ |
Dec 27, 16:00
1.13
-0.02
(-1.74%)
After-Hours: 20:00
Galectin Therapeutics Research and Development Expense (Annual): 32.13M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Alaunos Therapeutics Inc | 16.28M |
| SELLAS Life Sciences Group Inc | 24.01M |
| Oragenics Inc | 15.49M |
| Anavex Life Sciences Corp | 41.84M |
| Phathom Pharmaceuticals Inc | 49.90M |